Cardinal Health, Inc. $CAH Stock Bought by CoreCap Advisors LLC

CoreCap Advisors LLC grew its position in Cardinal Health, Inc. (NYSE:CAH) by 8.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 36,654 shares of the company’s stock after buying an additional 2,947 shares during the quarter. CoreCap Advisors LLC’s holdings in Cardinal Health were worth $8,133,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in CAH. Valeo Financial Advisors LLC grew its holdings in shares of Cardinal Health by 7.4% during the third quarter. Valeo Financial Advisors LLC now owns 3,076 shares of the company’s stock valued at $684,000 after buying an additional 213 shares in the last quarter. Vista Investment Partners LLC purchased a new stake in Cardinal Health in the 3rd quarter worth about $4,812,000. Alkeme Wealth LLC lifted its stake in Cardinal Health by 2.3% in the 3rd quarter. Alkeme Wealth LLC now owns 12,372 shares of the company’s stock worth $2,753,000 after acquiring an additional 281 shares in the last quarter. Venture Visionary Partners LLC boosted its position in Cardinal Health by 20.9% during the 3rd quarter. Venture Visionary Partners LLC now owns 2,870 shares of the company’s stock worth $639,000 after acquiring an additional 497 shares during the period. Finally, Elevation Wealth Partners LLC boosted its position in Cardinal Health by 35.3% during the 3rd quarter. Elevation Wealth Partners LLC now owns 207 shares of the company’s stock worth $46,000 after acquiring an additional 54 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Jason Hollar sold 80,000 shares of the business’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total value of $18,859,200.00. Following the completion of the sale, the chief executive officer owned 235,132 shares of the company’s stock, valued at $55,430,017.68. The trade was a 25.39% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Jessica Mayer sold 29,436 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total value of $6,952,488.84. Following the sale, the insider owned 33,076 shares of the company’s stock, valued at approximately $7,812,220.44. This trade represents a 47.09% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 210,271 shares of company stock valued at $49,626,657. Insiders own 0.12% of the company’s stock.

Cardinal Health Price Performance

CAH traded up $6.99 during midday trading on Thursday, hitting $239.15. 1,537,871 shares of the company’s stock traded hands, compared to its average volume of 1,973,910. The company has a market cap of $55.38 billion, a PE ratio of 33.08, a price-to-earnings-growth ratio of 1.40 and a beta of 0.50. The stock’s fifty day simple moving average is $233.15 and its 200-day simple moving average is $220.53. Cardinal Health, Inc. has a one year low of $151.87 and a one year high of $258.30.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The company had revenue of $63.67 billion during the quarter, compared to the consensus estimate of $65.15 billion. During the same period in the previous year, the firm posted $2.08 earnings per share. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, research analysts expect that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Analysts Set New Price Targets

Several research analysts have weighed in on CAH shares. Wells Fargo & Company upped their price objective on shares of Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Robert W. Baird lifted their target price on shares of Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research note on Wednesday, August 12th. UBS Group boosted their price target on shares of Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Evercore reiterated an “outperform” rating and set a $270.00 price objective on shares of Cardinal Health in a report on Wednesday, August 12th. Finally, JPMorgan Chase & Co. increased their price objective on Cardinal Health from $215.00 to $260.00 and gave the stock a “neutral” rating in a report on Thursday, August 13th. Sixteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $266.56.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.